Notification of Full Year Results (6483Z)
March 20 2012 - 3:01AM
UK Regulatory
TIDMIMM
RNS Number : 6483Z
Immupharma PLC
20 March 2012
FOR IMMEDIATE RELEASE 20 MARCH 2012
ImmuPharma plc
Notification of Full Year Results
Date: 27 March 2012
ImmuPharma plc (AIM: IMM), the specialist drug development
company, is scheduled to announce its Preliminary Results for the
year ended 31 December 2011 on Tuesday 27 March 2012.
A lunch briefing for analysts and private client brokers will be
held at 12.00pm on the day of the results at the offices of
Buchanan, 107 Cheapside, London EC2V 6DN.
- Ends -
For further information please contact:
ImmuPharma plc + 44 (0) 20 7152 4080
Dimitri Dimitriou, Chief Executive
Officer
Lisa Baderoon, Head of Investor
Relations
lisa.baderoon@immupharma.com + 44 (0) 7721 413496
Buchanan + 44 (0) 20 7466 5000
Mark Court, Jessica Fontaine
Panmure, Gordon & Co., NOMAD
& Broker +44 (0) 20 7459 3600
Andrew Burnett
Rakesh Sharma
Espirito Santo Investment Bank +44 (0) 20 7456 9191
James Bromhead
Richard Crawley
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORKMGMFNLMGZZM
Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024